Advanced search×

[Role of vascular endothelial growth factor and monocyte chemoattractant protein-1 in the development of endothelial dysfunction in types 1 and 2 diabetes mellitus complicated by diabetic retinopathy].

V V VV Nikitina, N B NB Zakharova, and T G TG Kamenskikh

Klin Lab Diagn (2011) PMID 21851000

The paper presents the results of a study of the serum levels of monocyte chemoattractant protein-1 (MCP-1) and vascular endothelial growth factor (VEGF) in 120 patients with types 1 and 2 diabetes mellitus complicated by diabetic retinopathy. All the patients with diabetes have been ascertained to show a rise in the levels of MCP-1 and VEGF. Calculation of VEGF/MCP-1 ratio is proposed to evaluate vascular bed lesion in diabetic patients.

Version: za2963e q8za1 q8zb5 q8zc2 q8zd5 q8zee q8zfc q8zga

Similar articles you may find interesting…

  1. Nitric Oxide Induces Vascular Endothelial Growth Factor Expression in the Rat Placenta in Vivo and in Vitro.
    Hideaki Abe, Wataru Ishikawa, and Tatsuya Takizawa

    Biosci Biotechnol Biochem (2013) PMID 23649256

    We investigated the role of nitric oxide (NO) in vascular endothelial growth factor (VEGF) expression in the rat placenta. A nitric oxide synthase (NOS) inhibitor, N(G)-nitro-L-arginine-methyl ester (L-NAME), was constantly infused into pregnant rats 6-24 h before sacrifice on gestational day (GD) 1...
  2. Cell-cell interaction between vocal fold fibroblasts and bone marrow mesenchymal stromal cells in three-dimensional hyaluronan hydrogel.
    Xia Chen and Susan L Thibeault

    J Tissue Eng Regen Med (2013) PMID 23653427

    We investigated cell morphology, survival rate, proliferation and protein and gene expression of VFFs and BM-MSCs. BM-MSCs inhibited cell proliferation of both normal and scarred VFFs without changes in VFF morphology or viability. BM-MSCs demonstrated decreased proliferation and survival rate after...
  3. Assessment of VEGF and MMP-9 in the Periodontium of Rats Treated with Atorvastatin.
    Umut Balli, Gonca Cayir Keles, and Deniz Erdogan

    J Periodontol (2013) PMID 23646851

    Systemic and local atorvastatin applications showed beneficial effect on periodontium in all three different periods. Within the limits of this study, it can be concluded that atorvastatin which is used for hypercholesterolemia treatment can also be used as a protective and therapeutic agent for per...